Evaluation of metabolic dysfunction-associated steatotic liver disease (MASLD) terminology in different clinical settings

Fecha de publicación: 01/03/2024 Fecha Ahead of Print: 01/02/2024

Autores de IDIVAL

Abstract no disponible

Iruzubieta P:: Instituto de Investigación. Gastroenterology and Hepatology Department, Marqués de Valdecilla University Hospital, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Santander, Spain
Santos-Laso A:: Instituto de Investigación. Gastroenterology and Hepatology Department, Marqués de Valdecilla University Hospital, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Santander, Spain
Arias-Loste MT:: Instituto de Investigación. Gastroenterology and Hepatology Department, Marqués de Valdecilla University Hospital, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Santander, Spain
Calleja JL:: Gastroenterology Department, Hepatology Unit, Hospital Universitario Puerta de Hierro, IDIPHISA, Madrid, Spain
Crespo J:: Instituto de Investigación. Gastroenterology and Hepatology Department, Marqués de Valdecilla University Hospital, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Santander, Spain